Non-Fiction Books:

Assessing the impact of a safe and equitable biosimilar policy in the United States

Sorry, this product is no longer available to order

Here are some other products you might consider...

Assessing the impact of a safe and equitable biosimilar policy in the United States

hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, May 2, 2007.
Click to share your rating 0 ratings (0.0/5.0 average) Thanks for your vote!
Unavailable
Sorry, this product is no longer available to order

Description

Assessing the impact of a safe and equitable biosimilar policy in the United States: hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, May 2, 2007.
Release date NZ
October 20th, 2019
Audience
  • General (US: Trade)
Imprint
Independently Published
Pages
192
Publisher
Independently Published
Dimensions
178x254x10
ISBN-13
9781700993427
Product ID
32079217

Customer reviews

Nobody has reviewed this product yet. You could be the first!

Write a Review

Marketplace listings

There are no Marketplace listings available for this product currently.
Already own it? Create a free listing and pay just 9% commission when it sells!

Sell Yours Here

Help & options

Filed under...